<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>ALCORTIN - hydrocortisone and iodoquinol gel </strong><br>Primus Pharmaceuticals<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Alcortin 1% iodoquinol - 2% hydrocortisone
with Aloe</h1>
<div class="Contents">
<div class="Section" data-sectionCode="51945-4">
<a name="section-1"></a><p></p>
<h1>Alcortin 2.0 g  ucarton.jpg</h1>NDC 68040-702-13 Rx only<br>Alcortin<br>Anti-fungal<br>Anti-bacterial<br>Anti-inflammatory<br>1% Iodoquinol 2% Hydrocortisone <br>See product literature for complete information.<br><span class="Bold">TO OPEN A SINGLE PACK</span>: Tear at notch along dotted line on front of package.<br><span class="Bold">DOSAGE</span>: Apply to affected area 3-4 times daily or as directed by your physician.<br><span class="Bold">CONTENTS</span>: This carton contains 24 single packs of 2.0 grams each of Alcortin gel. Each gram of<br>Alcortin contains 2.0% (20 mg) Hydrocortisone and 1.0% (10 mg) lodoquinol. Also contains 1.0%<br>(10 mg) Aloe polysaccharide and 5.0% (50 mg) Biopeptide combination of Palmitoyl oligopeptide,<br>Polyglyceryl methacrylate and Propylene glycol. Other ingredients: Aminomethyl propanol, Benzyl<br>alcohol, Blue 1, Carbomer, Fragrance, Glycerin, Magnesium aluminum silicate, PPG-20 methyl<br>glucose ether, Propylene glycol, Purified water, SO alcohol 40-B and Yellow 10.<br><span class="Bold">WARNING</span>: Keep out of reach of children. Not for use on infants or under diapers or occlusive<br>dressings. For external use only. Avoid contact with eyes. May discolor skin, hair or fabrics.<br>www.alcortin.com<br>U.S. Patents #6,436,679; #6,271 ,214;<br>#6,133,440; #5,708,038; patent pending<br>2004 Primus Pharmaceuticals, Inc. All rights reserved.<br>Distributed by:<br>Primus Pharmaceuticals, Inc.<br>Scottsdale, AZ 85254<br>www.primusrx.com<br>Manufactured by:<br>Harmony Labs, Inc.<br>Landis, NC 28088<br>NDC 68040-702-13<br>Rx only<br><span class="Bold">Alcortin</span><br>1% iodoquinol - 2% hydrocrtisone <br>Anti-fungal<br>Anti-bacterial<br>Anti-inflammatory<br>24 PACK<br><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> tested<br>Paraben free<br>Contains moisturizers<br>For dermatological use only<br>Each pack contains<br>multiple doses<br>(depending on the surface area treated)<br>NetWt 48.0g(1.69 oz)<br>24 packs of 2.0g(0.07 oz) each<br><span class="Bold">NDC 68040-702-13</span><br><span class="Bold">Alcortin</span><br>1% iodoquinol - 2% hydrocrtisone<br><span class="Bold">Rx only</span><br>Anti-fungal<br>Anti-bacterial<br>Anti-inflammatory<br><span class="Bold">NDC 68040-702-13</span><br><span class="Bold">Rx only</span><br>Alcortin<br>1% iodoquinol - 2% hydrocrtisone<br>Anti-fungal<br>Anti-bacterial<br>Anti-inflammatory<br>Paraben free<br>
Contains moisturizers<br>
For dermatological use only<br>Each pack contains<br>multiple doses<br>NetWt 48.0g(1.69 oz)<br>
24 packs of 2.0g(0.07 oz) each<br>multiple doses<br>(depending on the surface area treated)<br><div class="Figure"><img alt="U Caton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=995ae132-8e37-4fda-b353-ce79ab9d0bf4&amp;name=ucarton.jpg"></div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-2"></a><p></p>
<h1>Alcortin 2 g packet.jpg</h1>NDC 68040-702-02 Rx only<br>Alcortin gel 1% iodoquinol - 2% hydrocortisone with Aloe<br><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> tested - Paraben free<br>Contains moisturizers<br>For dermatological use only<br>Each pack contains multiple doses(depending upon the surface area treated)<br>NetWt. 2.0 g (0.07oz)<br>See product literature for complete information.<br>Dosage: Apply to affect area 3-4 times daily or as directed by your physician.<br>To Open: Tear at notch along dotted line on front of package.<br>Contents: Each gram of Alcortin contains 2.0% (20 mg Hydrocortisone and 1.0% (10 mg) Iodoquinol.<br>Also contains 1.0% (10 mg) Aloe polysaccharide and 5.0% (50 mg) Biopeptide combination of Palmitoyl oligopeptide, Poyglyceryl methacrylate and Propylene glycol. Other ingredients: Aminomethyl propanol, Benzyl alcohol, Blue 1, Carbomer, Fragrance, Glycerin, Magnesium aluminum silicate, PPG-20 methyl glucose ether, Propylene glycol, Purified water, SD alcohol 40-B and Yellow 10.<br>Warning: Keep out of reach of children. Not for use on infants or under diapers or occlusive dressings. For external use only. Avoid contact with eyes. May discolor skin, hair or fabrics.<br>www.alcortin.com<br>Distributed by: Primus Pharmaceuticals, Inc.<br>Scottsdale, AZ 85254<br>Manufactured by: Harmony Labs, Inc.<br>Landis, NC 28088<br>U.S. Patents #6,436,679; #6,271,214; #6,133,440; #5,708,038; patent pending<br><div class="Figure"><img alt="Packet" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=995ae132-8e37-4fda-b353-ce79ab9d0bf4&amp;name=packet.jpg"></div>
</div>
<div class="Section" data-sectionCode="48780-1">
<a name="section-3"></a><p></p>
</div>
<div class="Section" data-sectionCode="42230-3">
<a name="section-3"></a><p></p>
<h1>Insert</h1>
<p class="First">Prescribing Information<br><span class="Bold">ALCORTIN</span><span class="Bold">gel</span><br><span class="Bold">DESCRIPTION</span><br>Each gram of Alcortin contains 2.0% (20 mg)<br>Hydrocortisone and 1.0% (10 mg) lodoquinol.<br>Also contains 1.0% (10 mg) Aloe polysaccharide<br>and 5.0% (50 mg) Biopeptide combination<br>of Palmitoyloligopeptide, Polyglycerylmethacrylate<br>and Propylene glycol. Other<br>ingredients: Aminomethyl propanol, Benzyl<br>alcohol, Blue 1, Carbomer, Fragrance, Glycerin,<br>Magnesium aluminum silicate, PPG-20 methyl<br>glucose ether, Propylene glycol, Purified water,<br>SO alcohol 40-B and Yellow 10.<br><span class="Bold">lodoquinol</span><br>lodoquinol is an antifungal and antibacterial<br>agent. Chemically, lodoquinol is [5,7-diiodo-8-<br>quinolinol] with the molecular formula<br>(C9HsI2NO) <br><span class="Bold">Hydrocortisone</span><br>Hydrocortisone is an anti-inflammatory and<br>antipruritic agent. Chemically, hydrocortisone is<br>[Pregn-4-ene-3, 20-dione, 11, 17, 21- trihydroxy-,<br>(11 B)-] with the molecular formula<br>(C21H300s) <br><span class="Bold">CLINICAL PHARMACOLOGY</span><br>Hydrocortisone has anti-inflammatory, antipruritic<br>and vasoconstrictive properties. While the<br>mechanism of anti-inflammatory activity is<br>unclear, there is evidence to suggest that a recognizable<br>correlation exists between vasoconstrictor<br>potency and therapeutic efficacy in<br>humans. lodoquinol has both antifungal and<br>antibacterial properties.<br><span class="Italics">Pharmacokinetics</span><br>The extent of percutaneous absorption of topical<br>steroids is determined by many factors<br>including the vehicle, the integrity of the epidermal<br>barrier and the use of occlusive dressings.<br>Hydrocortisone can be absorbed from normal<br>intact skin. <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">Inflammation</span> and/or other inflammatory<br>disease processes in the skin increase<br>percutaneous absorption. Occlusive dressings<br>substantially increase the percutaneous<br>absorption of topical corticosteroids. Once<br>absorbed throuah the skin. hvdrocortisone is<br>tetrahydrocortisone and tetrahydrocortisol.<br>These are excreted in the urine, mainly conjugated<br>as glucuronides, together with a very<br>small proportion of unchanged hydrocortisone.<br>There are no data available regarding the percutaneous<br>absorption of iodoquinol; however,<br>following oral administration, 3-5% of the dose<br>was recovered in the urine as a glucuronide.<br><span class="Bold">INDICATIONS AND USAGE</span><br>Based on a review of a related drug by the<br>National Research Council and subsequent<br>FDA classification for that drug, the indications<br>are as follows: "Possibly" Effective: Contact or<br><span class="product-label-link" type="condition" conceptid="133834" conceptname="Atopic dermatitis">atopiC dermatitis</span>; impetiginized <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>; nummular<br><span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>; endogenous chronic infectious<br><span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span>; <span class="product-label-link" type="condition" conceptid="4148876" conceptname="Stasis dermatitis">stasis dermatitis</span>; <span class="product-label-link" type="condition" conceptid="133547" conceptname="Pyoderma">pyoderma</span>; nuchal<br><span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span> and chronic eczematoid <span class="product-label-link" type="condition" conceptid="380731" conceptname="Otitis externa">otitis externa</span>;<br><span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> urticata; localized or disseminated <span class="product-label-link" type="condition" conceptid="4148920" conceptname="Neurodermatitis">neurodermatitis</span>;<br>lichen simplex chronicus; anogenital<br><span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> (vulvae, scroti, ani); <span class="product-label-link" type="condition" conceptid="4029295" conceptname="Folliculitis">folliculitis</span>; bacterial<br>dermatoses; mycotic dermatoses such as <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span><br>(capitis, cruris, corporis, pedis); monliasis; intertrigo.<br>Final classification of the less-than-effective<br>indications requires further investigation.<br><span class="Bold">CONTRAINDICATIONS</span><br>Alcortin is contraindicated in those patients with<br>a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to hydrocortisone,<br>iodoquinol, aloe vera, glycine, histidine, lysine,<br>palmitic acid or any other components of the<br>preparation.<br><span class="Bold">WARNINGS AND PRECAUTIONS</span><br>For external use only. Keep away from eyes. If<br>irritation develops, the use of Alcortin should be<br>discontinued and appropriate therapy instituted.<br>Staining of the skin, hair and fabrics may occur.<br>Not intended for use on infants or under diapers<br>or occlusive dressings. If extensive areas are<br>treated or if the occlusive dressing technique is<br>used, the possibility exists of increased systemic<br>absorption of the corticosteroid, and suitable<br>precautions should be taken. Children may<br>absorb proportionally larger amounts of topical<br>corticosteroids and thus be more susceptible to<br>systemic toxicity. Parents of pediatric patients<br>should be advised not to use tight-fitting diapers<br>or plastic pants on a child being treated in the<br>diaper area, as these garments may constitute<br>occlusive dressings. lodoquinol may be<br>absorbed through the skin and interfere with<br><span class="product-label-link" type="condition" conceptid="4261836" conceptname="Thyroid panel">thyroid function tests</span>. If such tests are contemplated,<br>wait at least one month after discontinuance<br>of therapy to perform these tests. The ferric<br>chloride test for <span class="product-label-link" type="condition" conceptid="432872" conceptname="Phenylketonuria">phenylketonuria</span> (PKU) can<br>yield a false positive res!Jlt if iodoquinol is present<br>in the diaper or urine. Prolonged use may<br>result in overgrowth of non-susceptible organisms<br>requiring appropriate therapy. Keep out of<br>reach of children. Burning, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, irritation and<br>dryness have been reported infrequently following<br>the use of topical corticosteroids.<br><span class="Italics">Carcinogenesis, Mutagenisis and Impairment of<br>Fertility</span>: Long term animal studies have not<br>been performed to evaluate the carcinogenic<br>potential of the effect on fertility of hydrocortinegative<br>results. Mutagenicity studies have not<br>been performed with iodoquinol.<br>Pregnancy Category C: Animal reproductive<br>studies have not been conducted with Alcortin.<br>It is not known whether Alcortin can cause fetal<br>harm when administered to pregnant women or<br>can affect reproductive capacity. Alcortin<br>should be given to pregnant women only if<br>clearly needed.<br><span class="Italics">Nursing Mothers</span>: It is not known whether this<br>drug is excreted in human milk. Because many<br>drugs are excreted in human milk, caution<br>should be exercised when Alcortin is administered<br>to a nursing woman.<br>Pediatric Use: Safety and effectiveness in pediatric<br>patients under the age of 12 have not been<br>established.<br><span class="Bold">ADVERSE REACTIONS</span><br>The following local adverse reactions are<br>reported infrequently with topical corticosteroids.<br>These reactions are listed in an approximate<br>decreasing order of occurrence. Burning,<br><span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, irritation, dryness, <span class="product-label-link" type="condition" conceptid="4029295" conceptname="Folliculitis">folliculitis</span>, <span class="product-label-link" type="condition" conceptid="443793" conceptname="Hypertrichosis">hypertrichosis</span>,<br><span class="product-label-link" type="condition" conceptid="4299558" conceptname="Acneiform eruption">acneiform eruptions</span>, hypopigmentation,<br><span class="product-label-link" type="condition" conceptid="135032" conceptname="Dermatitis due to substances taken internally">perioral dermatitis</span>, <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">allergic contact dermatitis</span>,<br>maceration of the skin, <span class="product-label-link" type="condition" conceptid="442777" conceptname="Generalized infection during labor">secondary infections</span>,<br><span class="product-label-link" type="condition" conceptid="134118" conceptname="Atrophic condition of skin">skin atrophy</span>, <span class="product-label-link" type="condition" conceptid="137054" conceptname="Skin striae">striae</span> and <span class="product-label-link" type="condition" conceptid="4273714" conceptname="Miliaria">miliaria</span>.<br><span class="Bold">DOSAGE AND ADMINISTRATION</span><br>Apply to affected area 3-4 times daily in accordance<br>with physician's directions or as directed<br>otherwise by a physician.<br><span class="Bold">HOW SUPPLIED</span><br>FORM NDC # 68040-702-13 .<br>48.0 gram carton of 24-count of 2.0 gram gel individual packs<br>FORM NDC # 68040-702-02<br>2.0 gram gel individual pack<br>FORM NDC # 68040-702-08<br>10 count carton of 2.0 gram gel sample packs - not for resale<br>Each 2.0 gram gel pack contains multiple doses<br>depending on the surface area treated.<br><span class="Bold">STORAGE</span><br>Store at room temperature 15°-30°C (59°-86°F).<br>Keep tightly closed.<br><span class="Bold">Rx only</span> www.alcortin.com<br>U.S. Patents<br>#6,436,679; #6,271 ,214; #6,133,440;<br>#5,708,038; patent pending<br>Manufactured for:<br>Primus Pharmaceuticals, Inc.<br>Scottsdale, AZ 85254<br>www.primusrx.com<br><br></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ALCORTIN 		
					</strong><br><span class="contentTableReg">1% iodoquinol - 2% hydrocortisone gel</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:68040-702</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Hydrocortisone</strong> (Hydrocortisone) </td>
<td class="formItem">Hydrocortisone</td>
<td class="formItem">2 g  in 100 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>IODOQUINOL</strong> (IODOQUINOL) </td>
<td class="formItem">IODOQUINOL</td>
<td class="formItem">1 g  in 100 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:68040-702-08</td>
<td class="formItem">64  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:68040-702-02</td>
<td class="formItem">2 g in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:68040-702-13</td>
<td class="formItem">12  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">24  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">2 g in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">07/25/2003</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Primus Pharmaceuticals
							(130834745)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Harmony Labs, Inc. (105803274)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Harmony Labs, Inc.</td>
<td class="formItem"></td>
<td class="formItem">105803274</td>
<td class="formItem">manufacture, label, pack, repack, relabel</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>4acf85e5-f2d5-40b0-8562-2427a2ab56be</div>
<div>Set id: 995ae132-8e37-4fda-b353-ce79ab9d0bf4</div>
<div>Version: 3</div>
<div>Effective Time: 20100421</div>
</div>
</div> <div class="DistributorName">Primus Pharmaceuticals</div></p>
</body></html>
